Faeth Therapeutics FTH
NASDAQ FTH
$32.00 -0.10 (-0.31%)
At close: Aug 21, 2026 · 4:00 PM EDT

Faeth Therapeutics (FTH) Amortizatization of Intangibles (2020 - 2026)

Faeth Therapeutics' (FTH) quarterly Amortizatization of Intangibles came in at $1000.0 in Q1 2026, down 75.0% YoY from $4000.0 in Q1 2025, and down 75.0% on a QoQ basis from $4000.0 in Q4 2025.

Faeth Therapeutics (FTH) Amortizatization of Intangibles (2020 - 2026) Analysis & Trends

Faeth Therapeutics (FTH) has 6 years of Amortizatization of Intangibles data on file, last reported at $1000.0 in Q1 2026.

  • Quarterly Amortizatization of Intangibles fell 75.0% year-over-year to $1000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14000.0 (down 97.59% YoY) and the FY2025 annual result came in at $17000.0, down 97.8% from the prior year.
  • Amortizatization of Intangibles slipped to $1000.0 in Q1 2026, from $4000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $197000.0 in Q1 2023 to a low of $1000.0 in Q1 2026.
  • A 5-year average of $135411.8 and a median of $191000.0 in 2022 frame the typical range for Amortizatization of Intangibles.
  • Annual changes were most pronounced in 2023 — Amortizatization of Intangibles gained 11.3% — and 2025, when it sank 97.94%.
  • Tracing FTH's Amortizatization of Intangibles over 5 years: stood at $189000.0 in 2022, then gained by 2.65% to $194000.0 in 2023, then fell by 1.03% to $192000.0 in 2024, then plunged by 97.92% to $4000.0 in 2025, then slumped by 75.0% to $1000.0 in 2026.
  • The last three Amortizatization of Intangibles figures came in at $1000.0 (Q1 2026), $4000.0 (Q4 2025), and $4000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 678,000.00
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Faeth Therapeutics 179.31 Mn 179.31 Mn - 389,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 1,000.00
Mar 31, 2026 1,000.00
Dec 31, 2025 4,000.00
Dec 31, 2025 4,000.00
Sep 30, 2025 4,000.00
Sep 30, 2025 4,000.00
Jun 30, 2025 5,000.00
Jun 30, 2025 5,000.00
Mar 31, 2025 4,000.00
Mar 31, 2025 4,000.00
Dec 31, 2024 192,000.00
Dec 31, 2024 192,000.00
Sep 30, 2024 192,000.00
Sep 30, 2024 192,000.00
Jun 30, 2024 193,000.00
Jun 30, 2024 193,000.00
Mar 31, 2024 194,000.00
Mar 31, 2024 194,000.00
Dec 31, 2023 194,000.00
Dec 31, 2023 194,000.00